Literature DB >> 33046176

Country Quarantine During COVID-19: Critical or Not?

Noosha Samieefar1,2, Reza Yari Boroujeni2, Mahnaz Jamee3, Melika Lotfi4, Mohammad Rasul Golabchi5, Alireza Afshar6, Hamidreza Miri7, Mohammad Amin Khazeei Tabari8, Pouya Darzi8, Morteza Abdullatif Khafaie9,10, Bagher Amirheidari11,12, Amin Tamadon6,13, Niloofar Rambod Rad14, Nastaran Samimi15, Mojtaba Farjam15,16, Fatemeh Shiravi2, Narges Farshidi7, Mojtaba Hedayati Ch17,18, Donya Doostkamel19, Radin Alikhani19, Mahboobeh Razmkhah20, Saeed Abdollahifard20, Rasoul Nasiri Kalmarzi21, Roya Kelishadi22,23, Hosseinali Khazaei24,25, Asghar Aghamohammadi26,27, Farzaneh S Jafari Mousavi10, Morteza Shamsizadeh28,29, Arash Khojasteh2,30, Nima Rezaei26,31.   

Abstract

Entities:  

Keywords:  COVID-19; Iran; SARS-CoV-2; patient isolation; quarantine

Year:  2020        PMID: 33046176      PMCID: PMC7737116          DOI: 10.1017/dmp.2020.384

Source DB:  PubMed          Journal:  Disaster Med Public Health Prep        ISSN: 1935-7893            Impact factor:   1.385


× No keyword cloud information.
The new coronavirus, or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease (COVID-19), emerging from Wuhan, China, is the subject of attention in these days and the world news headlines.[1] The first case was reported on December 31, 2019, and the disease was declared a Public Health Emergency of International Concern by the World Health Organization (WHO), a month later, on January 30, 2020.[2] Iran is one of the most affected countries with more than 290 000 confirmed cases of COVID-19 (in April 29) and unfortunately more than 15 000 associated deaths. According to the geographic distribution data, all 31 provinces in Iran have been affected. The first 2 cases were announced in Qom and then north-central provinces became the hotspot regions, mainly capital cities. There is no specific medication or vaccine available for this infection, and other COVID-19 outbreaks seem to be inevitable; this emphasizes the need for finding the most beneficial preventive measures.[1] Isolation, quarantine, social distancing, and community containment are now the available options. Isolation for the purpose of symptomatic and non-infected individuals’ segregation does not appear to be sufficient alone due to the long incubation period of COVID-19. Quarantine as a previous successful measure during the SARS epidemic control in 2003, aiming to restrict the movement of suspected persons (maybe not infected or infected but without symptoms), could be beneficial. Social distancing is another option in which gatherings are reduced in order to avoid close contact of non-detected cases and with the community. The last strategy is community containment, as chosen by the Government of China. It is the restriction of the whole society and limiting the traffic to vital needs only.[3] However, a mass quarantine may increase anxiety, especially among those having previous psychiatric problems and the elderly, even causing other health problems.[4] In Iran, there is community transmission, which means the infection is expanding in numerous independent cluster.[5] Therefore, social distancing as done with the closure of schools and universities is beneficial and was fulfilled on February 23. Education guidelines, traveler screenings, charitable donations, the self-assessment system, and travel control may have also contributed to this outcome. The result was the decreasing number of confirmed cases in April. From the beginning of the epidemic, the government has emphasized social distancing rather than mass quarantine. Traveling between cities, although in a decline compared with that during previous years, was still taking place. In April 2020, the government decided to move the policy to smart social distancing while resuming social activities as before.[6] However, due to the reopening of the offices and increased hubbub, the number of infected individuals has been increasing with a stable trend. Some Asian countries have implemented successful strategies of pandemic control. The strategies were based on mostly transmission control via isolation and lockdowns, like what the Chinese Government did in Wuhan.[7] Although quarantining faces numerous obstacles, evidence supports its efficacy with emerging infectious diseases.[8] In Iran, the increased rate of transmission after returning the society to normal social activities resulted in an incremental trend. In conclusion, the best option available right now is transmission control. Infection cases must be detected promptly, isolated, and treated. However, isolation alone is not the answer; quarantine seems to be an advantageous tool, but its implementation needs resources. Furthermore, the entire society must be responsible and also educated about the disease. They should be aware of the alarming signs of the infection and should voluntarily quarantine themselves when having dubious mild symptoms or if they become exposed to a person who is infected with the new coronavirus. A group collaboration and awareness are needed to fight the pandemic successfully. “May the disease be controlled by all working side by side, as human beings are members of one another.”
  6 in total

Review 1.  Efficacy of Mass Quarantine as Leverage of Health System Governance During COVID-19 Outbreak: A Mini Policy Review.

Authors:  Mohammad Hossein Taghrir; Hossein Akbarialiabad; Milad Ahmadi Marzaleh
Journal:  Arch Iran Med       Date:  2020-04-01       Impact factor: 1.354

Review 2.  Iran Without Mandatory Quarantine and with Social Distancing Strategy Against Coronavirus Disease (COVID-19).

Authors:  Milad Abdi; Rasoul Mirzaei
Journal:  Health Secur       Date:  2020-05-27

3.  Weathering COVID-19 storm: Successful control measures of five Asian countries.

Authors:  Ning Lu; Kai-Wen Cheng; Nafees Qamar; Kuo-Cherh Huang; James A Johnson
Journal:  Am J Infect Control       Date:  2020-04-29       Impact factor: 2.918

4.  Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak.

Authors:  A Wilder-Smith; D O Freedman
Journal:  J Travel Med       Date:  2020-03-13       Impact factor: 8.490

Review 5.  The emotional impact of Coronavirus 2019-nCoV (new Coronavirus disease).

Authors:  Carlos Kennedy Tavares Lima; Poliana Moreira de Medeiros Carvalho; Igor de Araújo Araruna Silva Lima; José Victor Alexandre de Oliveira Nunes; Jeferson Steves Saraiva; Ricardo Inácio de Souza; Claúdio Gleidiston Lima da Silva; Modesto Leite Rolim Neto
Journal:  Psychiatry Res       Date:  2020-03-12       Impact factor: 3.222

Review 6.  Emerging coronaviruses: Genome structure, replication, and pathogenesis.

Authors:  Yu Chen; Qianyun Liu; Deyin Guo
Journal:  J Med Virol       Date:  2020-02-07       Impact factor: 2.327

  6 in total
  8 in total

Review 1.  Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.

Authors:  Kiarash Saleki; Shakila Yaribash; Mohammad Banazadeh; Ehsan Hajihosseinlou; Mahdi Gouravani; Amene Saghazadeh; Nima Rezaei
Journal:  Eur J Pharmacol       Date:  2021-06-12       Impact factor: 4.432

Review 2.  Biosensing surfaces and therapeutic biomaterials for the central nervous system in COVID-19.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  Emergent Mater       Date:  2021-03-10

Review 3.  Computational drug discovery and repurposing for the treatment of COVID-19: A systematic review.

Authors:  Kawthar Mohamed; Niloufar Yazdanpanah; Amene Saghazadeh; Nima Rezaei
Journal:  Bioorg Chem       Date:  2020-11-19       Impact factor: 5.275

Review 4.  A systematic review of pregnant women with COVID-19 and their neonates.

Authors:  Mona Mirbeyk; Amene Saghazadeh; Nima Rezaei
Journal:  Arch Gynecol Obstet       Date:  2021-04-02       Impact factor: 2.493

Review 5.  Delta Variant: The New Challenge of COVID-19 Pandemic, an Overview of Epidemiological, Clinical, and Immune Characteristics.

Authors:  Noosha Samieefar; Ronak Rashedi; Meisam Akhlaghdoust; Melika Mashhadi; Pouya Darzi; Nima Rezaei
Journal:  Acta Biomed       Date:  2022-03-14

6.  Bioinformatics Screening of Potential Biomarkers from mRNA Expression Profiles to Discover Drug Targets and Agents for Cervical Cancer.

Authors:  Md Selim Reza; Md Harun-Or-Roshid; Md Ariful Islam; Md Alim Hossen; Md Tofazzal Hossain; Shengzhong Feng; Wenhui Xi; Md Nurul Haque Mollah; Yanjie Wei
Journal:  Int J Mol Sci       Date:  2022-04-02       Impact factor: 5.923

Review 7.  Computed tomography scan in COVID-19: a systematic review and meta-analysis.

Authors:  Pouya Mahdavi Sharif; Mehran Nematizadeh; Mahdia Saghazadeh; Amene Saghazadeh; Nima Rezaei
Journal:  Pol J Radiol       Date:  2022-01-05

Review 8.  Flavonoids as Promising Antiviral Agents against SARS-CoV-2 Infection: A Mechanistic Review.

Authors:  Mohammad Amin Khazeei Tabari; Amin Iranpanah; Roodabeh Bahramsoltani; Roja Rahimi
Journal:  Molecules       Date:  2021-06-25       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.